ASA vs BST

ASA has a Piotroski F-Score of 6/9, indicating stable financial health, but lacks an Altman Z-Score, limiting bankruptcy risk assessment. The stock appears deeply undervalued based on a P/E of 5.13 versus sector average of 21.57 and trades well below both the Graham Number ($117.75) and intrinsic value estimate ($423.03), suggesting strong value potential. Exceptional profitability metrics including a 9430% profit margin and 60.9% ROE highlight operational efficiency, though negative ROA and missing Altman Z-Score raise asset utilization concerns. Despite strong historical price performance (+233.9% 1Y), weak technical trend (10/100) and lack of analyst coverage signal caution.

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 1/9, indicating weak fundamental strength. Despite a seemingly attractive P/E ratio of 8.54 and a high dividend yield of 7.35%, the complete absence of profitability metrics (0% margins across the board) and missing key financial data raise serious red flags. The technical trend is deeply bearish at 10/100, and insider sentiment is weak at 40/100, further undermining confidence. While the stock has delivered strong 3Y returns (+67.5%), current fundamentals do not support valuation at $40.80, especially with no Graham Number and limited financial transparency.